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The structural properties of alkyldihydroxyacetonephosphate synthase (ADPS) described by Razeto
et al. (2007) in this issue of Structure provide new insights into how this peroxisomal flavoenzyme
catalyzes a nonredox reaction in the conversion of an ester to an ether linkage in plasmologen
biosynthesis.Although only briefly mentioned in
standard biochemistry textbooks,
plasmologens have important func-
tional roles in numerous cellular sys-
tems as antioxidants, mediators in
membrane fusion processes, and
second messengers in signaling pro-
cess (Brites et al., 2004). The first two
steps in plasmologen biosynthesis
take place in peroxisomes, followed
by biosynthetic steps in the endoplas-
mic reticulum. Human disease states
arising from peroxisomal disorders
include Zellweger syndrome and three
subtypes of rhizometic chondrodys-
plasia punctata (RCDP) (Wanders and
Waterham, 2005). Clinical manifesta-
tions of reduced plasmologen levels
include growth and neurological ab-
normalities.
The peroxisomal enzyme involved in
the initial committed step in plasmolo-
gen biosynthesis (Figure 1) is alkyldi-
hydroxyacetonephosphate synthase
(ADPS). The first X-ray structure of
ADPS from Dictyostelium discoideum
is reported in this issue by Razeto
et al. (2007). ADPS crystallizes as a ho-
modimer with an FAD cofactor bound
in an extended conformation at the
catalytic site. An endogenous C-16
alcohol is bound in an 18 A˚ long hydro-
phobic tunnel that extends from the
protein surface to the active site. The
entrance to this tunnel is controlled by
a ‘‘gating helix’’ thought to be open in
the ligand-free enzyme but closed
when the alcohol is bound. As ex-
pected for an enzyme specific for
hydrophobic substrates, membrane
association of ADPS was previously
suggested by biochemical studies (de
Vet and van den Bosch, 2000). New
structural data show no specific mem-
brane spanning domain (e.g., a trans-membrane helix) but suggest that
membrane association occurs through
an electropositive patch which shares
residues with the gating helix. This
electropositive patch could have a
strong electrostatic interaction with
the electronegative phospholipids at
the membrane surface. The structural
data also suggest that a single sub-
strate tunnel leads to the active site
and plays a role in binding of the long
chain alkyl group of the substrate fatty
acid ester, release of the carboxylic
acid, binding of the long chain alcohol
substrate, and release of the alkyl
ether. This would be consistent with
the binary complex or ‘‘ping-pong’’
mechanism suggested by previous
steady state kinetic studies (Brown
and Snyder, 1982).
A key mechanistic question is how
the redox-functional FAD coenzyme
functions in a catalytic reaction which
involves no net oxidation-reduction.
The structural data identified Arg352Structure 15, June 2007 ªof D. discoideum ADPS as a key resi-
due in the flavin binding region. In hu-
man ADPS, Arg-to-His mutation at the
homolog position leads to ADPS inac-
tivation and gives rise to RCDP 3 (de
Vet et al., 1998). Interestingly, Arg352
is located on the face of the flavin op-
posite to where the substrate binds
which suggests a structural rather
than a catalytic role for this residue.
Mutation of an active site residue,
Tyr508, to a Phe also results in an in-
active enzyme suggesting an essential
role for the phenolic oxygen. Previous
work (de Vet et al., 2000) demon-
strated that the oxidized flavin absorp-
tion spectrum was converted to a
reduced-type spectrum on addition
of substrate at a rate consistent with
catalysis. The authors suggest that
this may result from H+ abstraction
from the C-10 position of the substrate,
leading to a carbanion intermediate,
able to react with the electron-defi-
cient flavin ring to form an alkyl adductFigure 1. Reaction Catalyzed by ADPS2007 Elsevier Ltd All rights reserved 639
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(A) Proposedmechanism for product ether bond formation utilizing an intermediate substrate carbanion intermediate forming an adduct with the FAD
coenzyme. (B) Proposedmechanism for ADPS catalysis involving a hydride transfer mechanismwith the FAD serving as hydride acceptor and donor.(Figure 2A). Precedent for this type of
reaction has been observed by the
interaction of nitroalkanes with flavo-
protein oxidases (Fitzpatrick, 2001).
The abstraction of a C-10 methylene
proton by an active site base would
be facilitated by the adjacent carbonyl
group at the 20 position of the sub-
strate. This mechanism is reasonable
although it requires the phenolic oxy-
gen of Tyr508 to be deprotonated, in
order to function as an active site
base, and facilitate alcohol addition
to the putative alkylated flavin adduct
of unknown structure.
An alternative mechanism centered
on Tyr508 would involve a hydrogen
atom abstraction by a putative tyrosyl
radical. The radical mechanism is un-
likely since previous stopped flow
spectral studies (de Vet et al., 2000)
showed no spectral evidence for the
intermediate formation and decay of
a tyrosyl radical.
The third possible mechanism is
based on the ability of flavin coen-
zymes to function as hydride accep-
tors and donors (Figure 2B). Flavoen-640 Structure 15, June 2007 ª2007 Elsevzyme participation in hydride transfer
reactions is documented in the litera-
ture by their well-known reactions
with pyridine nucleotides. They are
also known to serve as hydride accep-
tors in amino acid oxidases (Umhau
et al., 2000) and in other flavoenzymes
(Fitzpatrick, 2001). If the hydride trans-
fer reaction is to be consistent with
existing experimental data, the re-
duced flavin must be unreactive with
molecular oxygen and the hydrogen
derived from the substrate must return
to the catalytic intermediate during the
catalytic reaction. The first prediction
has not yet been experimentally tested
and the second is difficult to demon-
strate experimentally, since the enoli-
zation of the 20 carbonyl leads to
solvent exchange as observed experi-
mentally (Brown and Snyder, 1983).
The third prediction that the hydride
mechanism makes (Figure 2B) is that
both the alcohol and the acyl chain
must be bound in the active site simul-
taneously, which is contrary with the
observed ping-pong kinetic behavior.
Based on the structural data shown,ier Ltd All rights reservedthis is an unlikely scenario and the
carbanion mechanism proposed by
the authors appears to be more con-
sistent with both structural and kinetic
data.
The structural study of ADPS pro-
vides the basis for the future studies
of this important enzyme in plasmolo-
gen biosynthesis. The FAD coenzyme
in ADPS appears to have a unique
catalytic role relative to other flavoen-
zymes and should serve as an interest-
ing system for further mechanistic
investigations. It is also of further inter-
est to determine whether the mem-
brane-bound enzyme is dimeric and
similar to ADPS dimers found in the
crystal structure. Previous crosslinking
studies have demonstrated that ADPS
forms homodimeric and homotrimeric
structures in the membrane, as well
as a heterotrimeric structure with
dihydroxyacetone phosphate acyl
transferase, an enzyme that produces
the substrate for ADPS (Bierman
et al., 1999). Further studies are neces-
sary to identify the nature and site of
these interactions, to probe ADPS
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Previewregulation, and to determine if sub-
strate channeling occurs.
In conclusion, the structural elucida-
tion of ADPS opens the door to a more
detailed understanding of an impor-
tant peroxisomal enzyme involved in
the biosynthesis of plasmologens. It
also provides information on a protein
that harbors a known point mutation
which results in the peroxisomal disor-
der rhizomelic chondrodysplasia pun-
tata Type 3, a disease marked by
severe growth retardation, mental
retardation, rhizomelia, and early
death in afflicted patients (Wanders
and Waterham, 2006).REFERENCES
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